Tag: study

ROCKVILLE, Md. and SUZHOU, China, June 09, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that 13 studies of its core assets - including the novel drug olverembatinib (HQP1351), the investigational Bcl-2 inhibitor lisaftoclax (APG-2575), and the investigational EED inhibitor APG-5918 – will be featured in an oral presentation, multiple poster presentations and multiple online publications at the 2025 European Hematology Association (EHA) Annual Congress taking place in Milan, Italy, from June 12-15, 2025.

Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetes

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Core Banking Software Market size & share revenue was valued at approximately USD 15.83 Billion in 2024 and is expected to reach USD 17.94 Billion in 2025 and is expected to reach around USD 64.65 Billion by 2034, at a CAGR of 15.3% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Edgeverve Systems Limited (Infosys), Temenos Headquarters SA, Oracle Corporation, Fidelity National Information Services, Tata Consultancy Services Limited, Fiserv Inc., Intellect Design Arena Ltd., Finastra International Limited, Mambu GmbH, 10x Banking Technology Limited, SDK.finance, Backbase, nCino, SAP SE, CGI, Alkami Technology, Jack Henry & Associates, DeshDevs, Securepaymentz, Sopra Banking Software, and others.